HIV leucoencephalopathy and TNFα expression in neurones

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 7, 2005, Pages 960-964

  Rostasy, K ^b   Monti, L ^a   Lipton, S A ^d   Hedreen, J C ^a   Gonzalez, R G ^c   Navia, B A ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; CYTOKINE; SAQUINAVIR; STAVUDINE; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE; GLYCOPROTEIN GP 41;

ADULT; ARTICLE; BASAL GANGLION; BRAIN BIOPSY; CADAVER; CLINICAL ARTICLE; CLINICAL FEATURE; DEMENTIA; DEPRESSION; DISEASE COURSE; FRONTAL CORTEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LEUKOENCEPHALOPATHY; MACROPHAGE; MALE; MICROGLIA; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOPSY; BRAIN; CASE REPORT; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; FRONTAL LOBE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PATHOLOGY;

ADULT; AIDS DEMENTIA COMPLEX; ANTI-RETROVIRAL AGENTS; BASAL GANGLIA; BIOPSY; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FOLLOW-UP STUDIES; FRONTAL LOBE; HIV ENVELOPE PROTEIN GP41; HUMANS; MACROPHAGES; MALE; MICROGLIA; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEURONS; NEUROPSYCHOLOGICAL TESTS; SAQUINAVIR; STAVUDINE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; ZIDOVUDINE;

EID: 21344471428     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.036889     Document Type: Article

References (47)

1. Navia BA, Jordan B, Price RW. The AIDS dementia complex I: clinical features. Ann Neurol 1986;19:517-35.
2. Price RW, Brew B, Sidtis J, et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-92.
3. Glass JD, Wesselingh SL, Selnes OA, et al. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230-7.
4. Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting sole manifestation of human immunodeficiency virus infection. Arch Neurol 1987;44:65-9.
5. Luer W, Gerhards J, Poser S, et al. Acute diffuse leukoencephalitis in HIV-1 infection. J Neurol Neurosurg Psychiatry 1994;57:105-7.
6. Wiley C, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994;36:673-6.
7. Wiley C, Masliah E, Morey M, et al. Neocortical damage during HIV infection. Ann Neurol 1991;29:651-7.
8. Everall I, Luthert P, Lantos P. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991;337:1119-21.
9. Masliah E, Achim C, Ge N. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32:321-9.
10. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995;146:1121-30.
11. Levy RM, Roesenbloem L, Perrett LV. Neuroradiological findings in AIDS: a review of 200 cases. AJR Am J Roentgenol 1986;147:977-83.
12. Smirniotopoulos JG, Koeller KK, Nelson AM, et al. Neuroimaging-autopsy correlations in AIDS. Neuroimaging Clin N Am 1997;7:615-37.
13. Aylword EH, Brettschneider PD, McArthur JC, et al. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 1995;152:987-94.
14. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
15. Berger JR, Nath A, Greenberg RN, et al. Cerebrovascular changes in the basal ganglia with HIV dementia. Neurology 2000;54:921-6.
16. Schaefer PW, Gonzalez RG, Hunter G, et al. Diagnostic value of apparent diffusion coefficient hyperintensity in selected patients with acute neurologic deficits. J Neuroimaging 2001;11:369-80.
17. Adams DC, Wildemann B, Sasaki M, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp 41. Science 1996;274:1917-20.
18. Wesselingh SL, Power C, Glass JD, et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993;33:576-82.
19. Yeung MC, Pulliam L, Lau AS. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction or interleukin-6 and tumor necrosis factor. AIDS 1995;9:137-43.
20. Shi B, Raina J, Lorenzo A, et al. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-α: potentiation of neurotoxicity by oxidative stress and implications for HIV-1 dementia. J Neurovirol 1998;4:281-90.
21. Kaul M, Lipton S. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 1999;96:8212-16.
22. Giulian D, Vaca K, Noonan CA. Secretion of neurotoxins of mononuclear phagocytes infected with HIV-1. Science 1990;250:1593-6.
23. Rostasy K, Monti L, Kneissl M, et al. HIV infection, iNOS expression and microglial activation: pathogenetic relationship to the AIDS dementia complex. Ann Neurol 1999;46:207-16.
24. Glass JD, Fedor H, Wesselingh S, et al. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;38:755-62.
25. Wesselingh SL, Takahashi K, Glass JD, et al. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J Neuroimmunol 1997;74:1-8.
26. Rostasy K, Monti L, Yiannoutsos C, et al. NF-kB activation, TNF-α expression, and apoptosis in the AIDS dementia complex. J Neurovirol 2000;6:537-43.
27. New DR, Ma M, Epstein LG, et al. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 1997;3:168-73.
28. Talley A, Dewhurst S, Perry S. Tumor necrosis factor alpha induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crm-A. Mol Cell Biol 1995;15:2359-66.
29. Schmitt FA, Bigley JW, McKinnis R, et al. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1988;319:1573-8.
30. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990-1998. Neurology 2001;56:257-60.
31. Hedreen JC, Mucci LA. Antigen retrieval for paraffin section immunocytochemistry with antibodies commonly used in studies of degenerative diseases. Abstr Soc Neurosci, 1995;21:1802.
32. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1998;158:1079-83.
33. Bouwman FH, Skoloasky RL, Hes D, et al. Variable progression of HIV-associated dementia. Neurology 1998;50:1814-20.
34. Budka H, Wiley CA, Kleihues P. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991;1:143-52.
35. Smith TW, DeGirolami U, Henin D, et al. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol 1990;49:357-70.
36. Power C, Kong PA, Crawford TO, et al. Cerebral white matter changes in acquired human immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993;34:339-50.
37. Petito CK, Cash KS. Blood brain barrier abnormalities in the acquired immune deficiency syndrome: immunohistochemical localization of serum proteins to postmortem brains. Ann Neurol 1992;32:658-66.
38. Stout JC, Ellis RJ, Jernigan TL, et al. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal magnetic resonance imaging study. HIV neurobehavioural research center group. Arch Neurol 1998;55:161-8.
39. Seilhean D, Kobayashi K, He Y, et al. Tumor necrosis factor-α, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol 1997;93:508-17.
40. Fiala M, Looney DJ, Stins M, et al. TNF-α opens a poracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med 1997;3:553-64.
41. Cowan EP, Alexander RK, Daniel S, et al. Induction of tumor necrosis factor in human neuronal cells by extracellular T-cell lymphotropic virus type 1 Tax. J Virol 1997;71:6982-9.
42. Chen P, Mayne M, Power C, et al. The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J Biol Chem 1997;272:22385-8.
43. Khanna KV, Yu XF, Ford DH, et al. Differences among HIV-1 variants in their ability to elicit secretion of TNF-alpha. J Immunol 2000;164:1408-15.
44. Kadhim HJ, Tabarki-Mlaiki B, De Prez C, et al. Cytokine immunoreactivity in cortical and subcortical neuronal centers in periventricular leukomalacia. Ann Neurol 2000;48:528.
45. Mattson MP, Culmsee C, Yu Z, et al. Roles of nuclear factor kappoB in neuronal survival and plasticity. J Neurochem 2000;74:443-56.
46. Quasney MW, Zhang Q, Sargent S, et al. Increased frequency of the tumor necrosis factor-alpha-308 A allele in adults with human immunodeficiency virus dementia. Ann Neurol 2001;50:157-62.
47. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195-9.